197 related articles for article (PubMed ID: 16566612)
1. Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.
Trivedi MH; Rush AJ; Wisniewski SR; Warden D; McKinney W; Downing M; Berman SR; Farabaugh A; Luther JF; Nierenberg AA; Callan JA; Sackeim HA
J Clin Psychiatry; 2006 Feb; 67(2):185-95. PubMed ID: 16566612
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in depression: a STAR*D report.
Daly EJ; Trivedi MH; Wisniewski SR; Nierenberg AA; Gaynes BN; Warden D; Morris DW; Luther JF; Farabaugh A; Cook I; Rush AJ
Ann Clin Psychiatry; 2010 Feb; 22(1):43-55. PubMed ID: 20196982
[TBL] [Abstract][Full Text] [Related]
3. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.
Ishak WW; Balayan K; Bresee C; Greenberg JM; Fakhry H; Christensen S; Rapaport MH
Qual Life Res; 2013 Apr; 22(3):585-96. PubMed ID: 22544416
[TBL] [Abstract][Full Text] [Related]
4. Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D.
Ferguson M; Dennehy EB; Marangell LB; Martinez J; Wisniewski SR
Curr Med Res Opin; 2014 Oct; 30(10):2109-18. PubMed ID: 24949937
[TBL] [Abstract][Full Text] [Related]
5. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
[TBL] [Abstract][Full Text] [Related]
6. Major Depressive Disorder in Patients With Doctoral Degrees: Patient-reported Depressive Symptom Severity, Functioning, and Quality of Life Before and After Initial Treatment in the STAR*D Study.
Steiner AJ; Boulos N; Wright SM; Mirocha J; Smith K; López E; Gohar SH; Ishak WW
J Psychiatr Pract; 2017 Sep; 23(5):328-341. PubMed ID: 28961662
[TBL] [Abstract][Full Text] [Related]
7. Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study.
Woo JM; Jeon HJ; Noh E; Kim HJ; Lee SW; Lee KK; Kim SH; Hong JP
Health Qual Life Outcomes; 2014 Dec; 12():188. PubMed ID: 25519704
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
[TBL] [Abstract][Full Text] [Related]
9. Income and attrition in the treatment of depression: a STAR*D report.
Warden D; Rush AJ; Wisniewski SR; Lesser IM; Thase ME; Balasubramani GK; Shores-Wilson K; Nierenberg AA; Trivedi MH
Depress Anxiety; 2009; 26(7):622-33. PubMed ID: 19582825
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI treatment in the star*d trial.
IsHak WW; Mirocha J; Christensen S; Wu F; Kwock R; Behjat J; Pi S; Akopyan A; Peselow ED; Cohen RM; Elashoff D
Depress Anxiety; 2014 Aug; 31(8):707-16. PubMed ID: 23861180
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life and symptom severity in Chinese patients with major depressive disorder.
Cao Y; Li W; Shen J; Malison RT; Zhang Y; Luo X
Asia Pac Psychiatry; 2013 Dec; 5(4):276-83. PubMed ID: 23857826
[TBL] [Abstract][Full Text] [Related]
12. Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study.
DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Bodén R; Brandt L; Brenner P; Reutfors J; Li G
BMC Psychiatry; 2018 Oct; 18(1):352. PubMed ID: 30373547
[TBL] [Abstract][Full Text] [Related]
13. The effect of vortioxetine on health-related quality of life in patients with major depressive disorder.
Florea I; Danchenko N; Brignone M; Loft H; Rive B; Abetz-Webb L
Clin Ther; 2015 Oct; 37(10):2309-2323.e6. PubMed ID: 26346592
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D.
Yates WR; Mitchell J; Rush AJ; Trivedi MH; Wisniewski SR; Warden D; Hauger RB; Fava M; Gaynes BN; Husain MM; Bryan C
Gen Hosp Psychiatry; 2004; 26(6):421-9. PubMed ID: 15567207
[TBL] [Abstract][Full Text] [Related]
15. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.
Davis LL; Wisniewski SR; Howland RH; Trivedi MH; Husain MM; Fava M; McGrath PJ; Balasubramani GK; Warden D; Rush AJ
Drug Alcohol Depend; 2010 Mar; 107(2-3):161-70. PubMed ID: 19945804
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study.
Perlis RH; Fraguas R; Fava M; Trivedi MH; Luther JF; Wisniewski SR; Rush AJ
J Clin Psychiatry; 2005 Feb; 66(2):159-66; quiz 147, 273-4. PubMed ID: 15705000
[TBL] [Abstract][Full Text] [Related]
17. Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients.
Trivedi MH; Morris DW; Wisniewski SR; Nierenberg AA; Gaynes BN; Kurian BT; Warden D; Stegman D; Shores-Wilson K; Rush AJ
Can J Psychiatry; 2013 Feb; 58(2):113-22. PubMed ID: 23442899
[TBL] [Abstract][Full Text] [Related]
18. The health-related quality of life burden of co-morbid cardiovascular disease and major depressive disorder in Australia: findings from a population-based, cross-sectional study.
O'Neil A; Stevenson CE; Williams ED; Mortimer D; Oldenburg B; Sanderson K
Qual Life Res; 2013 Feb; 22(1):37-44. PubMed ID: 22323040
[TBL] [Abstract][Full Text] [Related]
19. Do atypical features affect outcome in depressed outpatients treated with citalopram?
Stewart JW; McGrath PJ; Fava M; Wisniewski SR; Zisook S; Cook I; Nierenberg AA; Trivedi MH; Balasubramani GK; Warden D; Lesser I; John Rush A
Int J Neuropsychopharmacol; 2010 Feb; 13(1):15-30. PubMed ID: 19341509
[TBL] [Abstract][Full Text] [Related]
20. Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life.
Zimmerman M; Ruggero CJ; Chelminski I; Young D; Posternak MA; Friedman M; Boerescu D; Attiullah N
J Clin Psychiatry; 2006 Oct; 67(10):1536-41. PubMed ID: 17107244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]